How much funding has Aura Biosciences raised?

Aura Biosciences has raised $233.9M in total funding, most recently a Series E round.

Who are Aura Biosciences's investors?

Aura Biosciences's investors include Advent Life Sciences, Medicxi, Matrix Capital Management, Surveyor Capital, Lundbeckfonden Ventures, Arix Bioscience plc.

When was Aura Biosciences founded?

Aura Biosciences was founded in 2009.

Where is Aura Biosciences headquartered?

Aura Biosciences is headquartered in Boston, Massachusetts, United States.

What industry is Aura Biosciences in?

Aura Biosciences operates in Biotech, Healthcare.

How many employees does Aura Biosciences have?

Aura Biosciences has 51-200 employees.

Aura Biosciences

IPO

Public · Boston, United States · Founded 2009 · $233.9M raised

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2009
Business Model: B2B
Website: aurabiosciences.com

Total Funding: $233.9M
Last Round: $80.5M Series EMar 2021
Rounds: 7
Type: Public

About

Oncology company leveraging targeted viral nanoparticle platform to develop treatments for ocular and other cancers.

Summary

Aura Biosciences is a Biotech company based in Boston, United States, founded in 2009. It has raised $233.9M in total across 7 rounds, most recently a $80.5M Series E round in Mar 2021. Investors include Advent Life Sciences, Medicxi and Matrix Capital Management.

LinkedIn X (Twitter)